Italy bans 7 APIs from compounding pharmacies after off-label abuse

By Fiona BARRY

- Last updated on GMT

Compounding pharmacies in Italy have been banned from working with certain APIs.
Compounding pharmacies in Italy have been banned from working with certain APIs.

Related tags Pharmacology

The Italian Ministry of Health has banned compounding pharmacies from preparing drugs containing any of seven APIs after chemists were discovered making dangerous off-label weight loss treatments.

The decree affects “abuses​” of the following active pharmaceutical ingredients:

  • TRIAC/tiratricol ​for thyroid problems and weight loss;
  • the antidepressants fluoxetine​ and bupropion​;
  • clorazepate​, a benzodiazepine;
  • furosemide​, a diuretic;
  • metformin​, for diabetes;
  • and the anticonvulsant topiramate​.

The ban, backed by the Italian Drug Agency (AIFA), comes after some compounding pharmacies created unregistered slimming drugs from combinations of APIs not intended for weight control.

Patients reported adverse reactions to the country’s pharmacovigilance network, and AIFA said such drugs “have an extremely unfavourable risk-benefit ratio and can be dangerous for those who use them.​”

The risk of adverse reactions goes up with the number of APIs in the drug preparation, the Ministry of Health added, saying the ingredients on its banned list can cause psychiatric and cardiovascular reactions.

Additionally, these combinations have never been tested in regular clinical trials, and lack the leaflet and information sheet to which the patient can refer to learn about the product​. The documentation available on the individual API does not guarantee its safety when administered in combination with another​”

The move follows two other decrees adopted by AIFA and the Health Minister in May and July which banned phenylpropanolamine/norephedrine and pseudoephedrine in diet drugs.

Related news

Show more

Related products

show more

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Thermo Fisher Scientific - Process Liquid Preparation Services | 21-Feb-2023 | Technical / White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Life Cycle Extension: A Molecule’s Full Potential

Life Cycle Extension: A Molecule’s Full Potential

Piramal Pharma Solutions | 16-Feb-2023 | Technical / White Paper

Winning approval for a new molecular entity is just a staging post on the journey of a drug. To maximize the benefits of a therapy, drugmakers need to...

INDENA ALWAYS AT THE FOREFRONT FOR CDMO SERVICES

INDENA ALWAYS AT THE FOREFRONT FOR CDMO SERVICES

Indena | 25-Oct-2022 | Technical / White Paper

Indena is well known in the space of naturally derived molecules, with a know-how developed over its one hundred year history. At the same time, the company...

Related suppliers

Follow us

Products

View more

Webinars